# Dechra

> Veterinary pharmaceuticals and products

Business model and tags: B2B, Pharma & life sciences, Sells to SMBs, PE-backed, Multi-site, International operations, Has production sites, Has in-house R&D, Has field sales reps, Has an SDR team, Sells through distributors, Has a works council

## About Dechra

Development, manufacture, and sales of high-quality veterinary pharmaceuticals and related products supporting veterinarians worldwide with training and information.

## Key facts

- **Industry**: Pharmaceutical Manufacturing
- **Company size**: 1,001–5,000 employees
- **Headquarters**: Northwich, England, United Kingdom
- **Founded**: 1997
- **Revenue**: £831M (FY2025, publicly reported)
- **Website**: [dechra.com](https://www.dechra.com/)
- **LinkedIn**: [linkedin.com/company/dechra-veterinary-products](https://www.linkedin.com/company/dechra-veterinary-products)

## Jobs at Dechra

- [Packer - Early shift](https://dechra.teamtailor.com/jobs/8568631-packer-early-shift) · Skipton, United Kingdom, United Kingdom · Oct 18, 2026
- [Territory Sales Manager - North West](https://www.linkedin.com/jobs/view/4476657040/) · Chester, England, United Kingdom, Remote · Oct 14, 2026
- [Quality Control Microbiologist](https://www.linkedin.com/jobs/view/4476453252/) · Fort Worth, TX, United States · Oct 13, 2026

[See all 14 openings](https://www.tamtam.ai/c/dechra/jobs)

## Dechra in the news

- [Dechra Finalizes Acquisition of Gallant Pet](https://todaysveterinarybusiness.com/dechra-finalizes-acquisition-of-gallant-pet/) · todaysveterinarybusiness.com · Nov 17, 2026
  Dechra acquired Gallant Pet to expand its therapeutic offerings with regenerative medicine and mesenchymal stromal cell therapies for animals.
- [Dechra acquires biotechnology company, Gallant Pet, Inc.](https://www.fidelity.com/news/article/mergers-and-acquisitions/202611171205PR_NEWS_USPR_____LN00024) · fidelity.com · Nov 17, 2026
  Dechra acquired the biotechnology company Gallant Pet, Inc.
- [Dechra Closes Gallant Pet Deal for Investigational Cell Therapies](https://www.securities.io/dechra-closes-gallant-pet-deal-for-investigational-cell-therapies/) · securities.io · Nov 17, 2026
  Dechra completed the acquisition of Gallant Pet, gaining a regenerative-medicine platform and pipeline for veterinary cell therapies.

[See all 20 articles](https://www.tamtam.ai/c/dechra/news)

## Dechra at a glance

Dechra is a B2B company in the Pharmaceutical Manufacturing industry, headquartered in Northwich, England, United Kingdom.

Dechra was founded in 1997.

Dechra has 1,001–5,000 employees.

Dechra's revenue is £831M (FY2025, publicly reported).

Dechra is hiring: 14 recent open roles, including Packer - Early shift, Territory Sales Manager - North West, Quality Control Microbiologist.

## Frequently asked questions about Dechra

### What is Dechra's revenue?

Dechra's revenue is £831M (FY2025, publicly reported).

### How many employees does Dechra have?

Dechra has 1,001–5,000 employees.

### Where is Dechra headquartered?

Dechra is headquartered in Northwich, England, United Kingdom.

---

Company data compiled by Tamtam from public sources and Tamtam's own analysis. Figures marked as estimates are modelled, not reported.

Source: https://www.tamtam.ai/c/dechra
